In an Intech article, Three strategies help life sciences companies implement more successful review by exception, Emerson’s Emilee Cook shares ways for these manufacturers to improve this workflow.
In a Jersey’s Best article, Powerful AI technology is changing the way N.J. operates, for the better, Emerson’s Dennis Belanger explains how AI is used, “…as a monitoring tool to understand the condition of eggs that are often used to create vaccines to combat the influenza virus…”
Have you wondered how some of the leading pharmaceutical and biopharmaceutical manufacturers have developed and tested their COVID-19 vaccine candidates in record time? In a Pharma Manufacturing article, The new requirement to fast-track vaccines, Emerson group president for the Systems and Software business, Jim Nyquist, shares ways in which these feats were accomplished.
Emerson’s Michalle Adkins will be discussing villains and heroes in knowledge management at the fully digital November 2-6, 2020 ISPE Annual Meeting and Expo.
The whitepaper, How to Simplify Your Pneumatic Valve Installation to Improve Your Drug Manufacturing Operation, highlights the critical role that pneumatic valve systems play across the drug development lifecycle—from drug discovery and production, to packaging and utilities.
Emerson’s Michalle Adkins and Ron Rossbach will host a webinar on reducing time to market for new therapies—a key opportunity for pharmaceutical and biopharmaceutical manufacturers. This webinar will take place on August 13 at 15:00 CET – Europe / 09:00 EDT.
For pharmaceutical and biopharmaceutical manufacturers, the Life Sciences.NOW webinar series includes eight interactive discussions on digital plant technologies and will provide direction and updates on key manufacturing operation initiatives to improve operational performance, deliver cost effective quality and regulatory compliance and accelerate the product development pipeline.
Emerson’s Michalle Adkins, Benjamin Arriola & Brandon Haschke are co-authors along with professionals in leading biopharmaceutical manufacturing and suppliers in the BioPhorum work, In-line monitoring / real-time release testing in biopharmaceutical processes – prioritization and cost benefit analysis.
Alan Johnston describes gene therapy, cell therapy and CAR-T which combines both. These have the goal to treat disease by changing the blueprint to our body at a microscopic level.
For biopharmaceutical producers, creating value from the knowledge capture and dissemination is paramount. At the upcoming February 23-26 IFPAC [International Foundation Process Analytical Chemistry] conference, Emerson’s Michalle Adkins will present on the impact of KM in product and process development for biopharmaceutical manufacturers.
Pharma 4.0 is an initiative based on Industry 4.0, begun out of the International Society for Pharmaceutical Engineering Germany/Austria/Switzerland (ISPE D/A/CH) organization, which lead to the formation of: …the ISPE Pharma 4.0 special interest group (SIG) in 2017....
Suppliers to the industry have been innovating to meet the single-use requirements of biotech manufacturers. Emerson’s Michalle Adkins pointed me to a recent award received for technology innovation for these single-use requirements.
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to keep up to date on all the latest news, events and innovations to help you take on and solve your toughest challenges.
Please do, Just link back to the post and send us a quick note so we can share your work. Thanks!
Our Global Community
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.